Skip to main content

VCPeer

Founder intelligence for smarter fundraising

Product

Browse VCs
All Reviews
Submit Review
Deal Flow
Raise Tracker
Compare VCs
Community
Retrospectives
Deal Room
Find Intros
Investor Updates
Deck Analytics

Tools

All Tools
Find Your VC
Term Sheet Analyzer
Compare VCs
Valuation Calculator
Cap Table Simulator
Term Sheet Benchmarks
Compensation Data
Negotiation Practice
SAFE Calculator
Runway Calculator
Data Room
Benchmarks
Raise Readiness

Resources

Fundraising Guide
Pitch Deck Guide
VC Glossary
Market Reports
Events
API Docs
Support
Open Data
Embed Widgets
API Status
Data Licensing

Community

Sectors
Stages
VC Locations
Weekly Digest
For VCs

Legal

Privacy Policy
Terms of Service
About

© 2026 VCPeer. All rights reserved.

Built by founders, for founders

Home Search Submit Pipeline Profile

Vivo Capital/DNA Profile

VC DNA Profile

Vivo Capital

Series ASeries BGrowthBiopharmaMedTechHealthcare Services

79

Good

Archetype

The Balanced Player

Response style: Moderately responsive

Best for: Founders raising Series A/Series B in Biopharma or MedTech

Founder Friendliness70

Founder-Friendly

Watch Out

No major red flags based on current data

Strengths

+Very low ghosting rate

Weaknesses

-Limited data for deeper analysis

Similar VCs

Norwest Venture Partners (Health)

Same stage focusComparable peer score

Sapphire Ventures (SAP Family)

Same stage focusComparable peer score

Norwest Venture Partners (FoW)

Same stage focusComparable peer score

Norwest Venture Partners

Same stage focusComparable peer score

← Back to Vivo Capital profile